Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000815786 | SCV000956258 | uncertain significance | RASopathy | 2018-11-04 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C35"). This variant has been observed in an individual with clinical features of Noonan syndrome (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamine with arginine at codon 22 of the NRAS protein (p.Gln22Arg). The glutamine residue is highly conserved and there is a small physicochemical difference between glutamine and arginine. |
Gene |
RCV004777892 | SCV005391968 | uncertain significance | not provided | 2024-04-08 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |